Wall Street Optimism Spills Over to These 10 Stocks on Friday

8. Hims & Hers Health Inc. (NYSE:HIMS)

Hims & Hers saw its share prices jump by 9.07 percent on Friday to finish at $45.09 apiece as investors resorted to bargain-hunting following a series of selling positions last week due to the Food and Drug Administration’s announcement that the blockbuster Wegovy and Ozempic drugs, which are manufactured by one of its competitors, has already been replenished.

It can be recalled that the FDA’s announcement took a toll on HIMS’ share prices, having lost 25.79 percent of its value in just the past week’s trading.

HIMS, a one-stop telehealth service for men’s care and wellness, has been making a compounded knock-off version of the blockbuster treatments.

In the fourth quarter of 2024, HIMS saw net income spike by 1,990 percent to $26.025 million from $1,245 million in the same period a year earlier, while revenues increased by 81 percent to $369.5 million from $204 million.

The company also swung to a net profit of $126 million from a net loss of $23.5 million in 2023 as revenues rebounded by 64 percent to $1.173 billion from $715 million.